[Commentary on] Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial Journal Article
| Author: | Dang, C. |
| Article Title: | [Commentary on] Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial |
| Keywords: | treatment outcomes; breast neoplasms -- drug therapy; fluorouracil -- therapeutic use; methotrexate -- therapeutic use; tamoxifen -- therapeutic use; radiotherapy -- utilization; cyclophosphamide -- therapeutic use; oophorectomy -- methods; goserelin -- therapeutic use; oophorectomy -- utilization |
| Journal Title: | Women's Oncology Review |
| Volume: | 1 |
| Issue: | 1 |
| ISSN: | 1473-3404 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2001-03-01 |
| Start Page: | 62 |
| End Page: | 63 |
| Language: | English |
| ACCESSION: | 2004135385 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Accession Number: 2004135385 -- Entry Date: 20040813 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Romeo D, Sismondi P et al -- Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial -- J CLIN ONCOL 2000; 18: 2718-27 -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20 |
MSK Authors
-
271Dang
Related MSK Work